• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 233/61 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Patent holdings for IPC class C07D 233/61

Total number of patents in this class: 370

10-year publication summary

21
16
23
24
15
16
21
9
24
6
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
University of Pittsburgh - Of the Commonwealth System of Higher Education
3256
7
BIAL - Portela & CA, S.A.
219
6
PTC Therapeutics, Inc.
487
6
Bristol-myers Squibb Company
4795
5
Merck Patent GmbH
5729
5
Centre National de La Recherche Scientifique
10812
5
Agency for Science, Technology and Research
3678
5
Institut Curie
605
5
Seren Technologies Limited
9
5
AstraZeneca AB
2828
4
Bayer Pharma AG
1036
4
President and Fellows of Harvard College
6054
4
Takeda Pharmaceutical Company Limited
2713
4
Dana-Farber Cancer Institute, Inc.
2637
4
EA Pharma Co., Ltd.
91
4
Toyama Chemical Co., Ltd.
96
4
The United States Government AS represented by The Department of Veterans Affairs
1275
4
Universite de Montpellier
1024
4
Nissan Chemical Corporation
2132
4
Risen (Suzhou) Pharma Tech Co., Ltd.
75
4
Other owners 277